Status: Not yet recruiting
An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases
Title: An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases
Participants needed: 94
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: ITabMed Co., Ltd.Updated: Oct 23, 2023
Eligibility criteria
18-75 years, all genders [+11]
Past or present malignant tumor diagnosed in the past 3 years and/or required tr... [+26]